Search
for
Sort by
Research 61–90 of 1000+
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Spironolactone use and the risk of breast cancer
- Male alopecia, finasteride, and cancer risk
- 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Additional file 4: of Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- A Case-Control Study of Dietary Phytoestrogens and Testicular Cancer Risk
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- S3 SERUM TRIGLYCERIDE CONCENTRATION AND RISK OF PROSTATE CANCER: A PROSPECTIVE MULTICENTER STUDY
- 343 RELATIONSHIP OF DIETARY INTAKE OF OMEGA-3 AND OMEGA-6 FATTY ACIDS WITH RISK OF PROSTATE CANCER DEVELOPMENT A META-ANALYSIS OF PROSPECTIVE STUDIES AND REVIEW OF LITERATURE
- Hair, Hormones, and High-Risk Prostate Cancer
- 15809 Spironolactone use does not increase the risk of estrogen-dependent cancer recurrence: A retrospective analysis
- Systematic Review of the Risk of Permanent Alopecia with Docetaxel Treatment for Breast Cancer
- Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use
- Use of hair products in relation to ovarian cancer risk
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- DNMT3B -579G>T POLYMORPHİSM AND THE RİSK OF COLORECTAL CANCER IN AZERBAİJAN POPULATİON
- A Cross-Sectional Study on Symptom Burden, Malnutrition Risk, Psychological Distress and Palliative Outcomes in Cancer Patients Undergoing Chemotherapy
- A Case-Control Study of Physical Activity, Obesity and Energy intake and the Risk of Kidney Cancer
- Could the use of personal care oils in black women contribute to recent findings of an increased risk of breast cancer in this population?
- Iron, Copper, and Magnesium Concentration in Hair and Risk of Esophageal Cancer: A Nested Case-Control Study
- What’s new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
- An overview of chemical straightening of human hair: technical aspects, potential risks to hair fibre and health and legal issues
- Understanding the role of sex hormones in cancer for the transgender community